Workshop faculty shared practical insights, debated sequencing, and identified opportunities to improve care for this rare, but important, disease.
Navigating the Evolving Treatment Landscape in HER2 Non–Small Cell Lung Cancer
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
Five Under 5: Top Oncology Videos for the Week of 1/25
5